-
27-05-2022, 11:31 AM
#20481
Originally Posted by winner69
Nice one baabaa
looks lie 20 cents here we come
I enjoyed selling shares about 150 ... those were the days -- twice
Is this really your prediction on where you believe SP is heading. What were the reasons that gave you the confidence holding up to $1.5 before selling, and what has all of a sudden changed on those parameters after this update. For the same reasons that was pushing the SP higher recently to it's most recent peak of $1.50 still hold. These recent results don't contradict anything to that matter and were in line with expectations. The adoption into US partnerships was slowed with the past 2 years of covid. However as the world comes out of that now then forward momentum with these channels should continue to be developed and grow. Hence why it appears this is now in oversold territory especially off these recent results.
Sizeable bids set at trigger 0.70 unfortunately didnt look like quite made it there. Will see how rest of day settles in. If I am wrong then might see 0.70 trigger (which upside would be good as ), but it appears might have missed the bottom of this slide and need to increase bid order. Will monitor and see where demand is suggesting momentum by close today.
-
27-05-2022, 11:49 AM
#20482
Originally Posted by Maxtrade
Is this really your prediction on where you believe SP is heading. What were the reasons that gave you the confidence holding up to $1.5 before selling, and what has all of a sudden changed on those parameters after this update. For the same reasons that was pushing the SP higher recently to it's most recent peak of $1.50 still hold. These recent results don't contradict anything to that matter and were in line with expectations. The adoption into US partnerships was slowed with the past 2 years of covid. However as the world comes out of that now then forward momentum with these channels should continue to be developed and grow. Hence why it appears this is now in oversold territory especially off these recent results.
Sizeable bids set at trigger 0.70 unfortunately didnt look like quite made it there. Will see how rest of day settles in. If I am wrong then might see 0.70 trigger (which upside would be good as ), but it appears might have missed the bottom of this slide and need to increase bid order. Will monitor and see where demand is suggesting momentum by close today.
that 20 cents no more logic than looking at baabaa's chart
Yep good times at 140 and above --- never worth that on fundamentals but sentiment / euphoria / irrationality is a great thing
First time was after Swanny bless his soul raved about tens of thousands of tests (or was it hundreds of thousands) and boy did that get punters excited and share price went to 170 and more recently David was a great story teller and all this transformational expansion ' contracts was wonderful and share price peaked again.
That's about it maxtrade - nothing to do with parameters or other fundamental stuff .... just market sentiment
That sucks at the moment eh .... maybe one day it will get exciting again .... you'd think they would be able to spin some great stories with all that cash in the bank.
Keeping an eye on the not so squiggly line on the chart .... might turn up one day for a bit more fun
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
27-05-2022, 11:54 AM
#20483
Originally Posted by Maxtrade
Is this really your prediction on where you believe SP is heading. What were the reasons that gave you the confidence holding up to $1.5 before selling, and what has all of a sudden changed on those parameters after this update. For the same reasons that was pushing the SP higher recently to it's most recent peak of $1.50 still hold. These recent results don't contradict anything to that matter and were in line with expectations. The adoption into US partnerships was slowed with the past 2 years of covid. However as the world comes out of that now then forward momentum with these channels should continue to be developed and grow. Hence why it appears this is now in oversold territory especially off these recent results.
Sizeable bids set at trigger 0.70 unfortunately didnt look like quite made it there. Will see how rest of day settles in. If I am wrong then might see 0.70 trigger (which upside would be good as ), but it appears might have missed the bottom of this slide and need to increase bid order. Will monitor and see where demand is suggesting momentum by close today.
I won't answer for Winner but being the experienced trader he/she is I expect it was a momentum/ hype play rather than anything fundamental.
But I will say that they have started to come clean now on the crap spun in the past. They now acknowledge that the tests are covered by CMS only when medically necessary (rather than implying that they were medically necessary). They still (revenue recognition notes p11) suggest they are being reimbursed by Insurers when I know most deem Cxbladder investigational and not covered. The deal with KP seems to be dragging into eternity. They acknowledge that the tests are not in the clinical pathway and need to get them ino the guidelines - and hence the belated push.
All these previous claims sent the SP to $1.50 and the market has been wildly patient (or jacked by a couple of instos' who have since sold down). The growth should be hockey stick style to support the SP anywhere near where it is even today - think how much you are paying!
And yet PE now acknowledge there is much work to still do.
Last edited by psychic; 27-05-2022 at 12:02 PM.
Reason: correct page no
-
27-05-2022, 11:55 AM
#20484
OOPs sorry Winner explained while I was replying.
Still overpriced at .30 but that is a gap worth looking at..
Last edited by psychic; 27-05-2022 at 11:57 AM.
-
27-05-2022, 12:01 PM
#20485
Blast from the past - 2013
The Pennsylvania lab has the capacity to process 260,000 tests a year and Mr Swann is confident the company will processing ''several tens of thousands of tests'' next year.
and
He reiterated earlier estimates, of achieving an annual $US100 million turnover within five years, noting that was a mid-range estimate.
Should note that even when raving about $US100 he really meant more because he seduced punters with that just being the mid range of estimates
Here's the ODT story from 2013 .... change a few names and they coud publish it again today
https://www.odt.co.nz/business/pacific-edge-business
Swann did decent thing back thing - sold a lot of shares at those inflated prices .... needed a new deck he said
Last edited by winner69; 27-05-2022 at 12:09 PM.
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
27-05-2022, 12:04 PM
#20486
I see too that in the notes thay have admitted that there is no more hope of getting paid for those 22000 tests completed for CMS.
I would have thought that this was worthy of a price sensitive announcement?
They did have to refund $143000 though for tests invoiced when they were later found not to be eligible for reimbursement
Last edited by psychic; 27-05-2022 at 12:11 PM.
-
27-05-2022, 12:04 PM
#20487
Somebody taking them over is really the only good outcome I reckon ....but it won't be the $2 billion somebody mentioned
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
27-05-2022, 12:09 PM
#20488
Originally Posted by winner69
Blast from the past - 2013
The Pennsylvania lab has the capacity to process 260,000 tests a year and Mr Swann is confident the company will processing ''several tens of thousands of tests'' next year.
and
He reiterated earlier estimates, of achieving an annual $US100 million turnover within five years, noting that was a mid-range estimate.
Should note that even when raving about $US100 he really meant more because he seduced punters with that just being the mid range of estimates
Here's the ODT story from 2013 .... change a few names and they coud publish it again today
https://www.odt.co.nz/business/pacific-edge-business
Yes, and then the sods sold!!
The Journalist confirmed to me that this was indeed what Swanny had said, Darling denied it.
Never seen a guy look quite as uncomfortable as Swan at the AGM
Last edited by psychic; 27-05-2022 at 12:15 PM.
-
27-05-2022, 12:15 PM
#20489
Originally Posted by winner69
that 20 cents no more logic than looking at baabaa's chart
Yep good times at 140 and above --- never worth that on fundamentals but sentiment / euphoria / irrationality is a great thing
First time was after Swanny bless his soul raved about tens of thousands of tests (or was it hundreds of thousands) and boy did that get punters excited and share price went to 170 and more recently David was a great story teller and all this transformational expansion ' contracts was wonderful and share price peaked again.
That's about it maxtrade - nothing to do with parameters or other fundamental stuff .... just market sentiment
That sucks at the moment eh .... maybe one day it will get exciting again .... you'd think they would be able to spin some great stories with all that cash in the bank.
Keeping an eye on the not so squiggly line on the chart .... might turn up one day for a bit more fun
The thing with PEB is when it rallies it rallies hard and fast. So if you aren't already in then overnight can miss out on large gains.
For example from May 29th - June 19th 2020 an increase in share price of 150%
From May to July 2020 increased 525%
From Aug to Dec 2020 another 90%
From March 2021 to April 2021 increased another 20%
From May 2021 to Aug 2021 increased another 20%
From Aug 2021 to Sept 2021 increased another 10%
Point being sold gains abruptly off short periods of time.
All it takes is for one of the partnerships to flourish this year (most likely in the US) and with that announcement would see a huge rally again in SP. With how far the current SP has fallen back it would in turn now be highly feasible to see an abrupt rally in SP of 220% pushing SP back up to the 1.4/1.5 with such news. That would be a gain we wouldn't want to miss out on sitting on the sidelines. The fact the instos are NOT selling is also positive. Cancer diagnostics and other health related issues that have been on the back burner during Covid, will ramp back up too the forefront as we now transition out of Covid globally. The states are already seeing more cancer and heart related patients prioritising. How many of us have put off checkups, skin cancer scans, prostate checkups, etc even dental appointments during Covid times. Normality will bring important matters such as cancers back to where they should be, top priority. The fact remains CX-bladder still offers a unique viable screening method that is just getting implemented and utilised in its largest market the US. The fact they were able to gain any traction during the last two years of Covid should be looked upon positively. The market can be harsh on SP with so many retail investors now, selling out of fear, buying out of FOMO. PEB still offers what it has, that has not changed and will continue to grow.
Last edited by Maxtrade; 27-05-2022 at 12:16 PM.
-
27-05-2022, 12:18 PM
#20490
Originally Posted by Maxtrade
The thing with PEB is when it rallies it rallies hard and fast. So if you aren't already in then overnight can miss out on large gains.
For example from May 29th - June 19th 2020 an increase in share price of 150%
From May to July 2020 increased 525%
From Aug to Dec 2020 another 90%
From March 2021 to April 2021 increased another 20%
From May 2021 to Aug 2021 increased another 20%
From Aug 2021 to Sept 2021 increased another 10%
Point being sold gains abruptly off short periods of time.
All it takes is for one of the partnerships to flourish this year (most likely in the US) and with that announcement would see a huge rally again in SP. With how far the current SP has fallen back it would in turn now be highly feasible to see an abrupt rally in SP of 220% pushing SP back up to the 1.4/1.5 with such news. That would be a gain we wouldn't want to miss out on sitting on the sidelines. The fact the instos are NOT selling is also positive. Cancer diagnostics and other health related issues that have been on the back burner during Covid, will ramp back up too the forefront as we now transition out of Covid globally. The states are already seeing more cancer and heart related patients prioritising. How many of us have put off checkups, skin cancer scans, prostate checkups, etc even dental appointments during Covid times. Normality will bring important matters such as cancers back to where they should be, top priority. The fact remains CX-bladder still offers a unique viable screening method that is just getting implemented and utilised in its largest market the US. The fact they were able to gain any traction during the last two years of Covid should be looked upon positively. The market can be harsh on SP with so many retail investors now, selling out of fear, buying out of FOMO. PEB still offers what it has, that has not changed and will continue to grow.
The announcements were crap!
The insto's have been selling down!
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks